Gilead Pharma corp withdraws investment arbitration after Ukraine agrees to settlement of dispute over monopoly rights to market anti-viral drug

5-avril-2017

Ukraine has settled a dispute with American pharmaceutical company Gilead Sciences Inc., following the company’s pursuit of legal remedies in both domestic courts and via investment arbitration.

Poster un commentaire

Qui êtes-vous ?
Votre message
  • Pour créer des paragraphes, laissez simplement des lignes vides.